Flexion Therapeutics Claimed Company
Flexion Therapeutics is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis (OA), a type of degenerative arthritis. read more
Melissa Layman ā Chief Commercial Officer at Flexion Therapeutics
Executive Bio
Ms. Layman joins Flexion with more than 25 years of commercial experience within the life science industry. Over the course of her career Ms. Layman has held positions of increasing responsibility within the sales, marketing, commercial and market access functions. Most recently, Ms. Layman served as Vice President, Global Sales and Marketing at Lantheus Medical Imaging where she was a member of the executive leadership team. During her nearly 10-year tenure, Ms. Layman was responsible for global sales, marketing, communications, health policy, pricing and reimbursement, commercial development and international operations. Prior to Lantheus, she served as Executive Marketing Director at Forest Labs (now Allergan), where she led the cardiovascular franchise through the successful launch of its lead product, Bystolic.
Executive Team Culture Ratings from Flexion Therapeutics Employees
TOP
5%
Flexion Therapeutics' Executive Team scores in the Top 5%
of similar sized companies on Comparably
of similar sized companies on Comparably
Flexion Therapeutics' Executive Team at a Glance
Based on 105 ratings, Flexion Therapeutics' employees are very satisfied with their Executive Team and give them an āA+ā or 95/100. On average, Women provided higher ratings for their Executive Team compared to Men. Also, the IT department thinks more highly of the Executive Team relative to the HR department.
Flexion Therapeutics' Executive Team ranks in the Top 5% of other companies in Boston and Top 5% of other companies on Comparably that also have 201-500 Employees.
×